CCL3 and Nasu-Hakola disease: CCL3 is a neutrophil chemoattractant and a direct stimulator of osteoclastogenesis, a process that together with bone remodeling is controlled by TREM2/DAP12 signaling and is altered in NHD patients [10, 63, 70, 75].